NextCure, Inc. — Director's Dealing 2019

May 9, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-08

Reporting Person: KABAKOFF DAVID S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	62237	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$7.63	2028-12-21	Common Stock (37342)		Direct

Footnotes

F1: One fourth of the option vests on December 21, 2019. The remainder vests in 36 monthly installments beginning on January 21, 2019.